Funder: Jerome Lejeune Foundation
Due Dates (Anticipated): February 2027 (full application deadline, projected)
Funding Amounts: Pilot: up to €50,000 over 2 years | Advanced: up to €80,000 over 2 years
Summary: Supports innovative research on genetic intellectual disabilities (excluding Trisomy 21), spanning fundamental, translational, clinical, epidemiological, and neuropsychological studies.
Key Information: Strict bioethics policy: no use of human embryonic/fetal tissues, IVF, or cloning-derived materials.